{
  "id": "ic-a4",
  "version": "1",
  "drug": {
    "slug": "glp-1-agonists",
    "display": "GLP-1 receptor agonists (semaglutide, tirzepatide, liraglutide)"
  },
  "supplement": {
    "slug": "chromium-picolinate",
    "display": "Chromium picolinate (200-1000 mcg/day)"
  },
  "severity": "caution",
  "evidenceTier": "pharmacology-standard",
  "mechanism": "Chromium may modestly improve insulin sensitivity; on top of a GLP-1 agonist a small additional glucose-lowering effect is theoretically possible. The evidence base is weaker than for berberine.",
  "patientNotes": [
    "Tell your prescriber you take chromium, especially if you have episodes of low blood sugar.",
    "Do not treat chromium as a substitute for glucose monitoring."
  ],
  "pmids": [
    "12664086"
  ],
  "pubmedUrls": [
    "https://pubmed.ncbi.nlm.nih.gov/12664086/"
  ],
  "guideSlugs": [
    "glp-1-companion-supplements",
    "supplements-for-mirtazapine-weight-gain"
  ],
  "guideUrls": [
    "https://supplementbrief.com/glp-1-companion-supplements/",
    "https://supplementbrief.com/supplements-for-mirtazapine-weight-gain/"
  ],
  "pairUrl": "https://supplementbrief.com/interactions/glp-1-agonists/chromium-picolinate/",
  "reviewedBy": "natallia-kalistratava",
  "reviewerUrl": "https://supplementbrief.com/authors/natallia-kalistratava/",
  "lastVerified": "2026-08-18",
  "jsonUrl": "https://supplementbrief.com/data/v1/pairs/ic-a4.json",
  "htmlUrl": "https://supplementbrief.com/data/v1/pairs/ic-a4/"
}
